Complementary cures tested

نویسندگان

چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Bloodletting & Miraculous Cures

is a collection of twelve short stories chronicling the lives of four physicians and the patients that they encounter. Bloodletting is an honest and revealing work, which entertains while challenging the reader to reflect on some of the ethical issues presented. The characters have strong initial presentation, but this falters towards the denouement. A scene in the anatomy lab introduces us to ...

متن کامل

Kif2a cures monopolar disorder

he Eg5 kinesin helps build a bipolar spindle by sliding microtubules past each other at the spindle midzone. On page 473, Ganem and Compton show that bipolarity requires another kinesin, called Kif2a, that localizes to spindle poles. Kif2a is strongly expressed in neuronal cells and is a member of a class of kinesins that depolymerize micro-tubules instead of stepping along their surface. The a...

متن کامل

Multibunch Instabilities and Cures

The common approach to achieve the high luminosity needed for high precision measurements adopted by the particle factories now under construction consists in storing high current e+ebeams distributed in many bunches in separate rings. The beams are brought together to collide at one interaction point. An inconvenience of this strategy is that the performances can be seriously limited by unstab...

متن کامل

A Richness that Cures

A study in Nature by Fischer et al. shows that environmental enrichment or increasing histone acetylation rescue the ability to form new memories and re-establish access to remote memories even in the presence of brain degeneration. Chromatin remodeling may be the final gate environmental enrichment opens to enhance plasticity and represents a promising target for therapeutical intervention in ...

متن کامل

The calculus of cures.

n engl j med 370;16 nejm.org april 17, 2014 1473 approved by the FDA since 2009 are for orphan diseases and cancers.1 This disproportion is not solely the result of scientific breakthroughs; the economics of drug development and the business of health care delivery also play large roles. Although these drugs may end up being critically important to patients with the targeted diseases, we believ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Nature

سال: 2008

ISSN: 0028-0836,1476-4687

DOI: 10.1038/453856a